Neuroendocrine tumors, version 1.2015.

Area of Science:

• Oncology
• Endocrinology
• Gastroenterology

Background:

• Neuroendocrine tumors (NETs) are a diverse group of neoplasms.
• NETs can manifest with or without hormonal hypersecretion symptoms.
• NCCN guidelines provide a framework for NET diagnosis and management.

Purpose of the Study:

• To present key aspects of the NCCN Clinical Practice Guidelines for Oncology.
• To focus on the diagnosis and management of sporadic NETs.
• To cover NETs of the pancreas, gastrointestinal tract, lung, and thymus.

Main Methods:

• Review of the NCCN Clinical Practice Guidelines for Neuroendocrine Tumors.
• Selection of content pertaining to sporadic NETs.
• Focus on specific anatomical locations: pancreas, GI tract, lung, thymus.

Main Results:

• Guidelines address both sporadic and hereditary NETs.
• This selection emphasizes sporadic NETs.
• Key sites include pancreas, GI tract, lung, and thymus.

Conclusions:

• NCCN guidelines offer comprehensive guidance for NET management.
• Sporadic NETs require specific diagnostic and management strategies.
• Understanding NETs across different organs is crucial for effective treatment.